Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Engels, C.C.

Refine Results

Resource Type

Availability

Creation Date

Show more

Language

Search results

  • RSS Feed
(1 - 20 of 30)

Pages

Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma
Tumor-infiltrating lymphocytes, tumor-associated macrophages and HLA class 1 expression in breast cancer patients treated with neoadjuvant chemotherapy with or without zoledronic acid: A sub study of the NEOZOTAC trial
Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma
10-year follow-up and biomarker discovery for adjuvant endocrine therapy; results of the TEAM trial
Integrating clinicopathological and molecular data in the breast cancer patient : towards precision medicine
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
Tumour immune subtyping as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression
Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?
DIFFERENT TUMOR BIOLOGY IN RUSSIAN AND DUTCH PATIENTS WITH BREAST CANCER STAGE I
OPINION How does genome sequencing impact surgery?
Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study

Pages